# N-acetylcysteine in the Treatment of Bulimia Nervosa

> **NCT01033149** · PHASE3 · TERMINATED · sponsor: **Lindner Center of HOPE** · enrollment: 11 (actual)

## Conditions studied

- Bulimia Nervosa

## Interventions

- **DRUG:** N-acetylcysteine

## Key facts

- **NCT ID:** NCT01033149
- **Lead sponsor:** Lindner Center of HOPE
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-12
- **Primary completion:** 2012-03
- **Final completion:** 2012-03
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2014-03-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01033149

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01033149, "N-acetylcysteine in the Treatment of Bulimia Nervosa". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01033149. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*